104 abstracts found.



Results filter

Introduction: selecting rational combinations for cancer and delivering early phase clinical trials in the UK

Year:

Session type: ,


Methodology to influence clinical practice in rare cancers

Year:

Session type: ,

Lucinda Billingham1

1Professor of Biostatistics, Director of Statistics, Cancer Research UK Clinical Trials Unit, School of Cancer Sciences and University of Birmingham


Introduction: rare tumours

Year:

Session type: ,


Introduction: microRNA and non-coding RNA

Year:

Session type: ,


The cost of cancer drugs in the US: why we must look beyond published data

Year:

Session type: ,

Tito Fojo1

1Columbia University Medical Center, New York, USA


Clash of cultures: the economic sustainability of cancer care and research across Europe

Year:

Session type: ,

Richard Sullivan1

1King’s College London, UK


Introduction: early diagnosis

Year:

Session type: ,


Introduction: advances in surgical oncology

Year:

Session type: ,


Introduction: tumour:stroma interactions

Year:

Session type: ,


Introduction: the future role of primary care in cancer control

Year:

Session type: ,


Introduction: prevention is better than cure’ – cancer chemoprevention in 2015

Year:

Session type: ,


Selective internal radiotherapy: microdosimetry, clinical research and patient advocacy

Year:

Session type: ,

Ricky Sharma1

1University of Oxford & Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, UK


Introduction: integration of germline genetic information can improve cancer diagnoses, treatment and prevention

Year:

Session type: ,


Introduction: cardiovascular toxicity in paediatric cancer treatment

Year:

Session type: ,


Investigating the genomic landscape of brain tumours using metabolic imaging

Year:

Session type: ,

1Kevin Brindle

1University of Cambridge, UK


Introduction: understanding the genomic landscape of brain cancer

Year:

Session type: ,


Opportunistic salpingectomy: development and implementation of an ovarian cancer prevention campaign

Year:

Session type: ,

Jessica McAlpine1

1University of British Columbia, Canada


Population-based approach(es) to genetic testing for ovarian cancer prevention

Year:

Session type: ,


Promoting physical activity among people living with advanced cancer

Year:

Session type: ,

Matthew Maddocks1

1King’s College London, UK


Reducing prostate cancer progression and mortality: what you can do to reduce your risk

Year:

Session type: ,

Stacey Kenfield1

1University of California, San Francisco & Harvard School of Public Health, Boston, USA


Introduction: physical activity – the panacea?

Year:

Session type: ,


Introduction: liquid biopsies with a twist: circulating cells and DNA

Year:

Session type: ,


Fc-mediated depletion of Tregs via ipilimumab-dependent ADCC in advanced melanoma patients

Year:

Session type: ,

Emaunela Romano1

1Institut Curie, Paris, France


BACR/AstraZeneca Young Scientist Frank Rose Award: Polyubiquitylaton drives replisome disassembly at the termination of eukaryotic DNA replication

Year:

Session type: ,

Agnieszka Gambus1

1University of Birmingham, UK


Introduction: genome instability: bench to bedside

Year:

Session type: ,


Introduction: everybody’s responsibility: systematic assessment of patient and carer needs in the oncology clinic and GP surgery

Year:

Session type: ,


Introduction: e-cigarettes and policy

Year:

Session type: ,

Linda Bauld


E-cigarettes: an evidence update

Year:

Session type: ,

Ann McNeill1

1King’s College London, London, UK


Targeting DNA repair in cancer treatment

Year:

Session type: ,

Thomas Helleday1

1Karolinska Institute, Stockholm, Sweden


Monitoring: How should we monitor our patients for cardiovascular toxicity? Serum biomarkers, imaging or both?

Year:

Session type: ,

Charlotte Manisty1

1University College London, University College London Hospital & Barts Heart Centre, London, UK


Master protocols in lung cancer

Year:

Session type: ,

Fred Hirsch1

1University of Colorado Cancer Center, Colorado, USA


Lung cancer profiling: the end of the beginning

Year:

Session type: ,

Fabrice Barlesi1

1Aix Marseille University, Assistance Publique Hopitaux de Marseille, Marseille, France


NCRI and NIHR initiatives in surgical oncology. Presentation of 2015 CREST award (Cancer Research Excellence in Surgical Trials)

Year:

Session type: ,

Richard Shaw1

1NIHR Clinical Research Network: Cancer & University of Liverpool, Liverpool, UK


‘Comic opera’ is dead… surgical research is alive and well

Year:

Session type: ,

Freddie C. Hamdy1

1University of Oxford, Oxford, UK


Pitfalls in surgical trials

Year:

Session type: ,

Emiel Rutgers1

1The Netherlands Cancer Institute, Amsterdam, The Netherlands


CReST trial: addressing surgical management of emergency oncology admissions and the role of randomised trials

Year:

Session type: ,

James Hill1

1Manchester Royal Infirmary, Manchester, UK,2Manchester Academic Health Science Center, Manchester, UK


miRNA as biomarkers for early lung cancer detection

Year:

Session type: ,

gabriella sozzi1

1Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy


Electronic Cigarettes – Are They Safe?

Year:

Session type: ,

Maciej Goniewicz1

1Roswell Park Cancer Institute, Buffalo, NY, USA


Germline genomics and predisposition to serious adverse drug reactions with anti-cancer drugs

Year:

Session type: ,

Munir Pirmohamed1

1University of Liverpool, Liverpool, UK


Interventional genetics

Year:

Session type: ,

John Burn1

1Newcastle University, Newcastle, UK


Primary prevention, symptomatic diagnosis and screening: roles for general practice and primary care

Year:

Session type: ,

David Weller1

1University of Edinburgh, Edinburgh, UK


Targeting tumour angiogenesis by targeting Angiopoietin/Tie signalling: from vascular regression over vascular normalisation to stromal reprogramming therapies

Year:

Session type: ,

Hellmut G. Augustin1

1Vascular Oncology and Metastasis, German Cancer Research Center, Heidelberg (DKFZ-ZMBH Alliance); Vascular Biology and Tumour Angiogenesis, Medical Faculty Mannheim (CBTM), Heidelberg University; Germ, Germany, Germany


Ovarian Cancer screening – update from UK trials

Year:

Session type: ,

Usha Menon1

1University College London, London, England, UK


Progressing radiotherapy-drug combinations towards early phase clinical trials

Year:

Session type: ,

Anthony Chalmers1

1University of Glasgow, Glasgow, UK


Cardiovascular toxicity in paediatric cancer treatment

Year:

Session type: ,

Steven Lipshultz1,2

1Children’s Hospital of Michigan, Detroit, Michigan, USA,2Wayne State University, Detroit, Michigan, USA


Integration of germline genetic information can improve cancer diagnosis, treatment and prevention

Year:

Session type: ,

Nazneen Rahman1,2

1Institute of Cancer Research, London, UK,2Royal Marsden, London, UK


The value of genomics in rare cancers.

Year:

Session type: ,

Ultan McDermott1

1Wellcome Trust Sanger Institute, Hinxton, UK


Treatment: How should we treat our patients who develop cardiovascular toxicity? How could we have prevented it?

Year:

Session type: ,

Chris Plummer1

1Freeman Hospital, Newcastle upon Tyne, UK


Therapeutic Implications of DNA repair defects in Metastatic Prostate Cancer

Year:

Session type: ,

Johann de Bono1,2

1The Institute of Cancer Research, London, UK,2Royal Marsden, London, UK


Genomic analysis of circulating tumour DNA: pushing the limits for cancer applications

Year:

Session type: ,

Nitzan Rosenfeld1,2

1Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK,2Inivata Ltd., Cambridge, UK